AAAAAA

   
Results: 1-18 |
Results: 18
HODGKINS-DISEASE IN THE ELDERLY - ANALYSIS ON A LARGE GROUP OF PATIENTS 65 YEARS AND OLDER
Authors: LEVIS A BOTTO B DEPAOLI L BERTINI M BARALDI A GALLAMINI A GAVAROTTI P PINI M SALVI F SCASSA E TERMINE G VITOLO U
Citation: A. Levis et al., HODGKINS-DISEASE IN THE ELDERLY - ANALYSIS ON A LARGE GROUP OF PATIENTS 65 YEARS AND OLDER, Annals of oncology, 9, 1998, pp. 118-118
HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH PBPC AUTOGRAFT AS PRIMARY-TREATMENT IN LOW-INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA
Authors: TARELLA C CARACCIOLO D CORRADINI P GAVAROTTI P ZALLIO F BIANCHI A NOVERO D ROSSI G PILERI A
Citation: C. Tarella et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH PBPC AUTOGRAFT AS PRIMARY-TREATMENT IN LOW-INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 612-612
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME
Authors: TARELLA C CASTELLINO C CHERASCO C BONDESAN P GIARETTA F CORRADINI P CARACCIOLO D GAVAROTTI P PILERI A
Citation: C. Tarella et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME, British Journal of Haematology, 99(1), 1997, pp. 41-46
CAUSES OF DEATH IN A LARGE GROUP OF PATIENTS TREATED FOR HODGKINS-DISEASE (HD)
Authors: LEVIS A SALVI F DEPAOLI L BOTTO B RICARDI U BERTINI M GALLAMINI A GAVAROTTI P NOVARINO A CAMBRIN GR SCALABRINI DR TERMINE G VITOLO U
Citation: A. Levis et al., CAUSES OF DEATH IN A LARGE GROUP OF PATIENTS TREATED FOR HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 3922-3922
LONG-TERM CLINICAL AND MOLECULAR FOLLOW-UP OF FOLLICULAR OR TRANSFORMED LYMPHOMA PATIENTS FOLLOWING FRONT-LINE HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY
Authors: TARELLA C CORRADINI P CARACCIOLO D GAVAROTTI P BIANCHI A ASTOLFI M ZAGLIO F PILERI A
Citation: C. Tarella et al., LONG-TERM CLINICAL AND MOLECULAR FOLLOW-UP OF FOLLICULAR OR TRANSFORMED LYMPHOMA PATIENTS FOLLOWING FRONT-LINE HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY, Blood, 90(10), 1997, pp. 501-501
RESULTS OF A LOW AGGRESSIVITY CHEMOTHERAPY REGIMEN (CVP CEB) IN ELDERLY HODGKINS-DISEASE PATIENTS/
Authors: LEVIS A DEPAOLI L BERTINI M BOTTO B CIRAVEGNA G FREILONE R GALLAMINI A GAVAROTTI P RICARDI U SCALABRINI DR SALOMONE A SALVI F VITOLO U PILERI A SANNAZZARI GL RESEGOTTI L
Citation: A. Levis et al., RESULTS OF A LOW AGGRESSIVITY CHEMOTHERAPY REGIMEN (CVP CEB) IN ELDERLY HODGKINS-DISEASE PATIENTS/, Haematologica, 81(5), 1996, pp. 450-456
HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY AS SALVAGE TREATMENT IN 33 PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA
Authors: TARELLA C CARACCIOLO D GAVAROTTI P CORRADINI P ZALLIO F CASTELLINO C PILERI A
Citation: C. Tarella et al., HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY AS SALVAGE TREATMENT IN 33 PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 3881-3881
HDS CHEMOTHERAPY AS UPFRONT TREATMENT IN 35 PATIENTS WITH INDOLENT LYMPHOMA INDUCES A HIGH-RATE OF DURABLE CLINICAL AND MOLECULAR REMISSION
Authors: TARELLA C CORRADINI P CARACCIOLO D ASTOLFI M CASTELLINO C GAVAROTTI P PILERI A
Citation: C. Tarella et al., HDS CHEMOTHERAPY AS UPFRONT TREATMENT IN 35 PATIENTS WITH INDOLENT LYMPHOMA INDUCES A HIGH-RATE OF DURABLE CLINICAL AND MOLECULAR REMISSION, Blood, 88(10), 1996, pp. 471-471
HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS
Authors: TARELLA C GAVAROTTI P CARACCIOLO D CORRADINI P CHERASCO C CASTELLINO C GALLO E PILERI A
Citation: C. Tarella et al., HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS, Annals of oncology, 6, 1995, pp. 3-8
CIRCULATING PROGENITORS FOLLOWING HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY WITH G-CSF - SHORT INTERVALS BETWEEN DRUG COURSES SEVERELY IMPAIRPROGENITOR MOBILIZATION
Authors: TARELLA C CARACCIOLO D GAVAROTTI P BONDESAN P CHERASCO C OMEDE P BREGNI M SIENA S GIANNI AM PILERI A
Citation: C. Tarella et al., CIRCULATING PROGENITORS FOLLOWING HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY WITH G-CSF - SHORT INTERVALS BETWEEN DRUG COURSES SEVERELY IMPAIRPROGENITOR MOBILIZATION, Bone marrow transplantation, 16(2), 1995, pp. 223-228
ROLE OF RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE TREATED WITH THE HYBRID MOPP ABVD (MAMA) REGIMEN/
Authors: LEVIS A DEPAOLI L RICARDI U BERTINI M BOTTO B CIRAVEGNA G GALLO E GAVAROTTI P CAMBRIN GR ROSSI M SALVI F RESEGOTTI I
Citation: A. Levis et al., ROLE OF RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE TREATED WITH THE HYBRID MOPP ABVD (MAMA) REGIMEN/, Blood, 86(10), 1995, pp. 196-196
FEASIBILITY AND TOXICITY OF HIGH-DOSE CHEMOTHERAPY WITH GROWTH-FACTORAND CIRCULATING PROGENITOR SUPPORT - THE EXPERIENCE IN 111 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS
Authors: TARELLA C CARACCIOLO D GAVAROTTI P CORRADINI P CASTELLINO C CHERASCO C BIANCHI A MASSAIA M PALUMBO A BOCCADORO M PILERI A
Citation: C. Tarella et al., FEASIBILITY AND TOXICITY OF HIGH-DOSE CHEMOTHERAPY WITH GROWTH-FACTORAND CIRCULATING PROGENITOR SUPPORT - THE EXPERIENCE IN 111 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS, Blood, 86(10), 1995, pp. 3857-3857
P-VEBEC - A NEW 8-WEEKLY SCHEDULE WITH OR WITHOUT RG-CSF FOR ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL)
Authors: BERTINI M FREILONE R VITOLO U BOTTO B PIZZUTI M GAVAROTTI P LEVIS A ORLANDI E ORSUCCI L PINI M SCALABRINI DR SALVI F SECONDO V TODESCHINI G VIERO P VOLTA C RESEGOTTI L
Citation: M. Bertini et al., P-VEBEC - A NEW 8-WEEKLY SCHEDULE WITH OR WITHOUT RG-CSF FOR ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL), Annals of oncology, 5(10), 1994, pp. 895-900
PROBABILITY OF CURE IN ELDERLY HODGKINS-DISEASE PATIENTS
Authors: LEVIS A DEPAOLI L URGESI A BERTINI M ORSUCCI L VITOLO U BUCHI G GALLAMINI A GAVAROTTI P NOVARINO A SCALABRINI DR MAZZA U PILERI A SANNAZZARI GL RESEGOTTI L
Citation: A. Levis et al., PROBABILITY OF CURE IN ELDERLY HODGKINS-DISEASE PATIENTS, Haematologica, 79(1), 1994, pp. 46-54
CLINICAL AND MOLECULAR MONITORING OF LOW INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA PATIENTS TREATED AT DIAGNOSIS WITH AN INTENSIFIED HDS REGIMEN
Authors: TARELLA C CORRADINI P CARACCIOLO D GAVAROTTI P ZALLIO F ASTOLFI M CHERASCO C PILERI A
Citation: C. Tarella et al., CLINICAL AND MOLECULAR MONITORING OF LOW INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA PATIENTS TREATED AT DIAGNOSIS WITH AN INTENSIFIED HDS REGIMEN, Blood, 84(10), 1994, pp. 10000165-10000165
HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY WITH BLOOD AND MARROW CELL AUTOGRAFT AS SALVAGE TREATMENT IN VERY POOR-PROGNOSIS, RELAPSED NON-HODGKINS-LYMPHOMA
Authors: CARACCIOLO D GAVAROTTI P AGLIETTA M BONDESAN P FALDA M GALLO E LOCATELLI F NOVARINO A PAOLINO F SANAVIO F URGESI A VITOLO U TARELLA C
Citation: D. Caracciolo et al., HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY WITH BLOOD AND MARROW CELL AUTOGRAFT AS SALVAGE TREATMENT IN VERY POOR-PROGNOSIS, RELAPSED NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 12(6), 1993, pp. 621-625
MYELOID LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES - CHEMICAL-EXPOSURE, HISTOLOGIC SUBTYPE AND CYTOGENETICS IN A CASE-CONTROL STUDY
Authors: CICCONE G MIRABELLI D LEVIS A GAVAROTTI P REGECAMBRIN G DAVICO L VINEIS P
Citation: G. Ciccone et al., MYELOID LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES - CHEMICAL-EXPOSURE, HISTOLOGIC SUBTYPE AND CYTOGENETICS IN A CASE-CONTROL STUDY, Cancer genetics and cytogenetics, 68(2), 1993, pp. 135-139
CIRCULATING PROGENITORS IN LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND G-CSF
Authors: TARELLA C CARACCIOLO D GAVAROTTI P BENEDETTI G BONDESAN P CASTELLINO C CHERASCO C PILERI A
Citation: C. Tarella et al., CIRCULATING PROGENITORS IN LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND G-CSF, Blood, 82(10), 1993, pp. 10000654-10000654
Risultati: 1-18 |